Cerep offers in vitro pharmacology, in vitro ADME-Tox and in vivo PK services, and provides solutions allowing faster and cost-effective drug discovery by identifying at early stages the most promising drug candidates as well as eliminating those compounds likely to fail in development. Cerep’s services benefit annually to about 500 pharmaceutical and biotechnological companies worldwide including most of the top pharmaceutical firms.
Type
Public
HQ
Celle-Lévescault, FR
Size (employees)
178 (est)
Website
cerep.fr
Eurofins-Cerep is headquartered in Celle-Lévescault, FR
Report incorrect company information

Eurofins-Cerep Office Locations

Eurofins-Cerep has offices in Celle-Lévescault, Saint Charles and Dundee Technology Park
Dundee Technology Park, GB
Gemini Cres Discovery House
Saint Charles, US
15 Research Park Dr
Show all (3)
Report incorrect company information

Eurofins-Cerep Financials and Metrics

Eurofins-Cerep Financials

Market capitalization (25-Jul-2017)

25.2 m

Closing share price (25-Jul-2017)

100
Eurofins-Cerep's current market capitalization is €25.2 m.
Show all financial metrics
Report incorrect company information